Advertisement

Rehabilitation and palliation of breast cancer patients

Chapter
  • 803 Downloads
Part of the Collection de L’Académie Européenne de Médecine de Réadaptation book series (LACADEMIE)

Abstract

The chief goal of all medical, potentially curative follow-up care measures (recurrence prophylaxis, early detection and therapy of disease recurrence) is to lengthen survival time. The actual cancer disease therefore represents the focus of curative follow-up care (fig. 1.1, 1.3).

Keywords

Breast Cancer Breast Cancer Patient Brain Metastasis Clin Oncol Breast Reconstruction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliographie

  1. — Aapro M, Cull A (1999) Depression in breast cancer patients: The need for Treatment. Ann Oncol 10: 627–36PubMedCrossRefGoogle Scholar
  2. — Ahles TA, Saykin AJ, Furstenberg CT et al. (2002) Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20: 485–93PubMedCrossRefGoogle Scholar
  3. — Anilo LM (2000) Sexual life after breast cancer. Journal of Sex & Marital Therapy 26,3: 241–8CrossRefGoogle Scholar
  4. — Altaha R, Abraham J (2004) Paraneoplastic neurologic syndrome associated with occult breast cancer. Breast J 9,5: 417–9CrossRefGoogle Scholar
  5. — Aspinal F, Hughes R, Higginson I et al. (2002) A user’s guide to the palliative care outcome scale. Palliative care & policy publications. Kings College, LondonGoogle Scholar
  6. — Avis N, Crawford S, Manuel J (2004) Psychosocial problems among younger women with breast cancer. Psycho-oncology 13,5: 295–308PubMedCrossRefGoogle Scholar
  7. — Bausewein C, Fegg M, Radbruch L et al. (2005) Validation and clinical application of the German version of the palliative care outcome. J Pain Symptom Manage 30: 51–62PubMedCrossRefGoogle Scholar
  8. — Balducci L, Extermann M, Carrera I (2001) Management of breast cancer in the older women. Cancer control 8,5: 431–41PubMedGoogle Scholar
  9. — Barat M, Franchignoni F (2004) Assesssment in physical medecine and rehabilitation. Maugeri Foundation books. PI-ME Press PaviaGoogle Scholar
  10. — Bartsch HH, Delbrück H, Kruck P et al. (2000) Zur Prozessqualität in der onkologischen Rehabilitation. Rehabilitation 39: 355–8PubMedCrossRefGoogle Scholar
  11. — Blakely J, Bulder A, Loleda JS et al. (2004) Effect of pregnancy after treatment for breast cancer. Cancer 100,3: 465–9PubMedCrossRefGoogle Scholar
  12. — Bottomley A (2000) Quality of life data interpretation: Key issues in advanced breast cancer. In: Nabholtz JM, Tonkin K, Aaapro M S et al. (edit) Breast cancer Management. Application of evidence to patient care. M Dunitz London 363–72Google Scholar
  13. — Buddeberg C, Wolf C, Sieber M et al. (1991) Coping strategies and course of disease of breast cancer patients. Psychother: Psychosom 55: 151–7CrossRefGoogle Scholar
  14. — Bourbonniere M, Kagan SH (2004) Nursing intervention and older adults who have cancer: Specific science and evidence based practice. Nurs Clin North Am 39: 529–43PubMedCrossRefGoogle Scholar
  15. — Bradley C, Oberst K, Schenk M (2006) Absenteeism from work: The experience of employed breast and prostate cancer patients in the months following diagnosis. Psychooncology 15,8: 739–47PubMedCrossRefGoogle Scholar
  16. — Bukovic D, Fajdic J, Hrgovic Z et al. (2004) Sexual dysfunction in breast cancer survivors. Onkologie 28,1: 29–34Google Scholar
  17. — Bundesarbeitsgemeinschaft für Rehabilitation (BAR) (2003) Rahmenempfehlungen zur ambulanten onkologischen RehabilitationGoogle Scholar
  18. — Burke W, Daly M, Garber J et al. (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer II BRCA1 and BRCA2. Cancer Studies Consortium; Ethical, Legal, and Social Implications Branch; National Centre for Human Genome Research. JAMA 277: 997–1003PubMedCrossRefGoogle Scholar
  19. — Calabrese C, Distante V, Orzalesi L et al. (2001) Immediate reconstruction with mammaplasty in conservative breast cancer treatment: Long-term results. Focus Rec Breast Cancer Surg, Osp Ital Chir 7: 38–46Google Scholar
  20. — Carlsson C, Baigi A, Killander D et al. (2005) Motives for becoming and remaining member of patient associations: A study of 1,810 Swedish individuals with cancer associations. Support Care Cancer 20Google Scholar
  21. — Caponigro F, Basile M, Rosa VD et al. (2004) New drugs in cancer therapy. Anticancer Drugs 16,2: 211–21CrossRefGoogle Scholar
  22. — Carter G, Gross A (2003) Bisphosphonates and avascular necrosis of the jaws. Aust Dent J 48: 268PubMedCrossRefGoogle Scholar
  23. — Cella D (1997) The functional assessment of cancer therapy anaemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(suppl 2): 13–9PubMedGoogle Scholar
  24. — Chanan-Khan A, Srinivasan S, Czuczman MS (2004) Prevention and management of cardiotoxicity from antineoplastic therapy. J Support Oncol 2,3: 251–6PubMedGoogle Scholar
  25. — Cuzick J, Stewart H, Peto R et al. (1987) Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71: 15–29PubMedGoogle Scholar
  26. — Daley, A (2007) Exercise progrecs improves well-being in survivors of breast cancer. J clin Oncol 25, 1713–21PubMedCrossRefGoogle Scholar
  27. — Delbrück H, Witte M (2006) Onkologische Nachsorge und Rehabilitation in Ländern der europäischen Gemeinschaft. (in press)Google Scholar
  28. — Deng G, Cassileth B, Yeung K (2004) Complementary therapy for cancer-related symptoms. J Supportive Oncol 2: 419–29Google Scholar
  29. — Deutsche Krebsgesellschaft (2004) Interdisziplinäre S3-Leitlinie für die Diagnostik und Therapie des mammakarzinoms der Frau. W Zuckschwerdt StuttgartGoogle Scholar
  30. — Di Stefano, Yap H, Blumenschein G (1979) The natural history of breast cancer patients with brain metastases. Cancer 44: 1913–8CrossRefGoogle Scholar
  31. — Dooren SV, Seynaeve C, Rijnburger AJ et al. (2005) The impact of having relatives affected with breast cancer on psychologic distress in women at increased risk for hereditary breast cancer. Breast Cancer Res Treat 89(1): 75–80PubMedCrossRefGoogle Scholar
  32. — Ernst E (edit) (2001) The desktop guide to complementary and alternative medecine. An evidence based approach. MosbyGoogle Scholar
  33. — Evans H, Lambert C (2007) Physiological basis of fatigue. An J Phys Med Rehabil 86,1: 29–6CrossRefGoogle Scholar
  34. — Extermann M, Overcash J, Lyman GH et al. (1998) Comorbidty and functional status are independen in older cancer patients. J Clin Oncol 16: 1582–7PubMedGoogle Scholar
  35. — Fallowfield L, Cella D, Cuzick J et al. (2004) Quality of life of postmenopausal women in the Arimedex, Tamoxifen, Alone or in Combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 22: 4261–71PubMedCrossRefGoogle Scholar
  36. — Fossati R, Confalonieri C, Torri V et al. (1998) Cytotoxic and hormonal treatment for metastatic breast cancer. A systematic review of published randomized trials involving 31,510 women. J Clin Oncol 16,10: 3439–60PubMedGoogle Scholar
  37. — Fromme E, Eilers KM, Mori M et al. (2004) How accurate is clinician reporting of chemotherapy adverse effects? J Clin Oncol 22,17: 3485–90PubMedCrossRefGoogle Scholar
  38. — Ganz P, Desmond K, Leedham B et al. (2002) Quality of life in long-term disease — free survivors of breast cancer: A follow-up study. J Natl Cancer Inst 94: 39–49PubMedGoogle Scholar
  39. — Ganz P, Greendale G, Petersen L et al. (2003) Breast cancer in younger women: Reproductive and late health effects of treatment. J Clin Oncol 21: 4184–93PubMedCrossRefGoogle Scholar
  40. — Geels P, Eisenauer E (2000) Palliative effect of chemotherapy. J Clin Oncol 18: 2395PubMedGoogle Scholar
  41. — Gelber S, Coates S, Goldhirsch A et al. (2001) Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19(6): 1671–5PubMedGoogle Scholar
  42. — Giordano SH, Buldak AU, Smith TS (2004) Is Breast cancer survival improving? Cancer 100,1: 44–52PubMedCrossRefGoogle Scholar
  43. — Goldhirsch A, Gelber R (2004) Life with consequences of breast cancer: Pregnancy during and after endocrine therapies. Breast 13: 443–5PubMedCrossRefGoogle Scholar
  44. — Goodwin P, Blau R, Gazder P et al. (1999) The risk of premature menopause induced by chemotherapy. J Womens Health Gend Based Med 8: 949–54Google Scholar
  45. — Grafe I, Fonseca KD, Hillmeier J (1999) Reduction of pain and fracture indidence after kyphoplasty. Osteoporosis Int 16: 2005–12CrossRefGoogle Scholar
  46. — Højris I, Overgaard M, Christensen JJ et al. (1999) Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Lancet 354: 1425–30PubMedCrossRefGoogle Scholar
  47. — Hillner BE et al. (2004) American society of clinical oncology 2003 update on the role of bispohosphonates and bone health issues in women with breast cancer. J Clin Oncol 21: 4042–57CrossRefGoogle Scholar
  48. — Hokin PJ, Yarnold JR, Roos DR et al. (2001) Second workshop on Palliative Radiotherapy and Symptom Control: Radiotherapy for bone metastases. Clin Oncol (R Coll Radiol) 13: 88–90Google Scholar
  49. — Hunter MS, Grunfield E, Mittal S et al. (2004) Menopausal symptoms in women with breast cancer: Prevalence and treatment preferences. Psycho-oncology 13,11: 769–78PubMedCrossRefGoogle Scholar
  50. — Jeziorowski M, Leuschner G, Schwerdtfeger R (1995) Gesundheitstraining in der onkologischen Rehabilitation. In Günther H, Ehninger G (edit) Individuelle Therapieentscheidungen bei unbegrenzten Möglichkeiten. Pechstein VerlagGoogle Scholar
  51. — Johnsson A, Fornander T, Olsson M et al. (2007) Factors associated with return to work after breast cancer. Acta Oncol 46,1: 90–6PubMedCrossRefGoogle Scholar
  52. — Kienle G, Kiene H, Albonico H (2006) Anthroposophic medicine. Effectiveness, utility, costs, safety. Schattauer, StuttgartGoogle Scholar
  53. — Kligman L, Wong PK, Johnston M et al. (2004) The treatment of lymph edema related to breast cancer: Asystematic review and evidence summary. Support Care Cancer 12,6: 421–31PubMedCrossRefGoogle Scholar
  54. — Knobf M (1999) The influence of symptom distress and preparation on responses of women with early stage breast cancer to induced menopause. Psycho oncology 8: 88aGoogle Scholar
  55. — Koski S, Venner P (2000) Chemotherapy-induced nausea and vomiting. In: Nabholtz JM, Tonkin K, Aapro MS, Buzdar AU (edit) Breast cancer management. Application of evidence to patient care. M Dunitz London 317–29Google Scholar
  56. — Krychman M, Pereira L, Carter J (2007) Sexual health issues in women with cancer. Oncology 71,1–2, 18–25Google Scholar
  57. — Kufe DW, Pollack RE, Weichselbaum RR et al. (2003) in Cancer Medicine, 6th ed. Hamilton, OntarioGoogle Scholar
  58. — Kuroi K, Shimozuma K (2004) Neurotoxicity of taxanes: Symptoms and quality of life assessment. Breast cancer 11,1: 92–9PubMedCrossRefGoogle Scholar
  59. — Kwaliteitsinstitut voor de Gezondheidszorg (2001) Behandeling van het Mammacarcinoom. CBO, http://www.cbo.nlGoogle Scholar
  60. — Laurer D, Connolly-Nelson K, Vang B (2007) Stressors and coping strategies among female cancer survivors after the treatment. Cancer nurs. 30,2: 101–11CrossRefGoogle Scholar
  61. — Lee S, Schover LR, Partridge A et al. (2006) American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients. J Clin Oncol 20, 24(18): 2917–31PubMedCrossRefGoogle Scholar
  62. — Liang W, Burnett CB, Rowland JH et al. (2002) Communication between physicians and older women with localized breast cancer: Implications for treatment and patient satisfaction. J Clin Oncol 20: 1008–16PubMedCrossRefGoogle Scholar
  63. — Lerman C, Biesecker B, Benkendorf JL et al. (1997) Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 89: 148PubMedCrossRefGoogle Scholar
  64. — Levine ERG, Eckhardt J, Targ E (2005) Change in post-traumatic stress symptoms following psychosocial treatment for breast cancer. Psycho-oncology 13Google Scholar
  65. — Limper AH (2004) Chemotherapy-induced lung disease. Clin Chest Med 25: 53–64PubMedCrossRefGoogle Scholar
  66. — Love W, Kissane D, Bloch S et al. (2002) Diagnostic efficiency of the hospital anxiety and depression scale in women with early stage breast cancer. Australian New Zealand J Psych 36: 246–50CrossRefGoogle Scholar
  67. — Manuel J, Burwell S, Cranford S et al. (2007) Younger women’s perceptions of coping with breast cancer. Cancer nurs 30,2: 85–94PubMedCrossRefGoogle Scholar
  68. — Maunsell E, Brisson C, Dubois L et al. (1999) Work problems after breast cancer: An exploratory qualitative study. Psycho-oncology 8,6: 467–73PubMedCrossRefGoogle Scholar
  69. — MacDonald N (edit) (1998) Palliative Medicine, a Case-Based Manual. Oxford, NY: Oxford University PressGoogle Scholar
  70. — Morandi P, Rouvier R, Altundag K (2004) The role of Aromatase inhibitors in the adjacent treatment of breast cancer. Cancer 101,7: 1482–9PubMedCrossRefGoogle Scholar
  71. — Mordenti C, Peris K, Couletta Fargnoli M et al. (2000) Cutaneous metastatic breast carcinoma. Acta dermatovenerologica 9, 4Google Scholar
  72. — Moser MT, Weis J, Bartsch HH (2001) Effects of oncological inpatient rehabilitation programs on quality of life. Psycho-oncology 10: 21Google Scholar
  73. — Nguyen T, DeAngelis L (2004) Treatment of brain metastases. J Support Oncol 2: 405–16PubMedGoogle Scholar
  74. — Nitz U (2004) Disease-management-Programm Mammakarzinom. Der Onkologe 10: 404–8CrossRefGoogle Scholar
  75. — Overmoyer B (2003) Combination chemotherapy for metastatic breast cancer: Reaching for the cure. J Clin Oncol 21(4): 580–2PubMedCrossRefGoogle Scholar
  76. — Paterson A, Lindasy MA (2000) Erythropoetin in the management of cancer patients. In: Nabholtz JM, Tonkin K, Aaapro MS, Buzdar AU (edit) Breast cancer Management. Application of evidence to patient care. M Dunitz London 311–6 In: Nabholtz, JM. K Tonkin, M S Aaapro, A U Buzdar (edit): Breast cancer Managment. Application of evidence to patient care. M Dunitz London 363–72Google Scholar
  77. — Pavlakis N, Stockler M (2002) Bisphosphonates in breast cancer (Cochrane Review). In: The Cochrane Library, issue 1, Oxford: Update softwareGoogle Scholar
  78. — Rabaglio M, Egli G, Castaglione M (2004) Edema after cancer treatment. Ther Umschau 61,11: 649–54CrossRefGoogle Scholar
  79. — Reidl IR (2002) Intavenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346: 653–61CrossRefGoogle Scholar
  80. — Resnick B, Belcher AE (2002) Breast Reconstruction. Am J Nurse. 102: 26–33Google Scholar
  81. — Rosner D, Flowers A, Lane WW (1993) Chemotherapy induces regression of brain metastases in breast carcinoma patients: Update study (abstract). Proc Am Soc Clin Oncol 12: A508Google Scholar
  82. — Rowett L (2000) The Internet, health professionals and the health consumer. In Nabholtz JM, Tonkin K, Aaapro MS, Buzdar A (edit) Breast cancer management. Application of evidence to patient care. Dunitz, London 539–47Google Scholar
  83. — Saunders C, Hickey M, Ives A (2004) Breast cancer during pregnancy. Int J Fertil Womens Med 49,5: 203–7PubMedGoogle Scholar
  84. — Schlesinger-Raab A, Eckel R, Engel J (2005) Metastasiertes Mammakarzinom: Keine Lebensverlängerung seit 20 Jahren. Dtsch. Ärztebl. 102,40: 2706Google Scholar
  85. — SIGN (1998) Breast cancer in women. http:www.sign.ac.uk/guidelines/published/index.htmlGoogle Scholar
  86. — Slimane K, Andre F, Delaloge S (2004) Risk factors for brain relapse in patients with metastastic breast cancer. Ann Oncol 15: 1640–4PubMedCrossRefGoogle Scholar
  87. — Sonmezer M, Oktay K (2004) Fertility preservation in female patients. Human Reproduction Update 10: 251–66PubMedCrossRefGoogle Scholar
  88. — Stevinson C (2001) Why patients use complemetary and alternative medecine. In: Ernst E (edit.) The desktop guide to complementary and alternative medecine. An evidence-based approach. MosbyGoogle Scholar
  89. — Stoeckli R, Keller U (2004) Nutritional fats and the risk of type 2 diabetes and cancer. Physiol Behav 83,4: 611–5PubMedCrossRefGoogle Scholar
  90. — Storey P (1998) Symptom control in dying. In: Berger A, Portenoy RK, Weissman D, eds. Principles and Practice of Supportive Oncology Updates. Philadelphia, Pa: Lippincott-Raven Publishers, 741–8Google Scholar
  91. — Teitelbaum SL, Britton JA, Gammon MD (2003) Occupation and breast cancer in women 20–44 years of age. Cancer Causes Control 14,7: 627–37PubMedCrossRefGoogle Scholar
  92. — Tennant A (2004) Principles and practice of measuring outcome in Barat M, Franchignoni F (edit) (2004) Assessment in physical medicine and rehabilitation. Maugeri Foundation books, PI-ME Press PaviaGoogle Scholar
  93. — The American Cancer Society Advisory Committee on Diet, Nutrition, and Cancer Prevention (1999) Guidelines on diet, nutrition, and cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 46: 325–41Google Scholar
  94. — Thorsen L, Skovlund E, Stromme SB et al. (2005) Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy. J Clin Oncol 23,10: 2378–88PubMedCrossRefGoogle Scholar
  95. — Twycross R, Lichter I (1998) The terminal phase. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2nd ed. Oxford, England: Oxford University Press, 985–6Google Scholar
  96. — Van Dalen E, Caron H, Dickinson H et al. (2005) Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database Syst Rev: CD 003917Google Scholar
  97. — Van Gils, Peeters PH, Bueno-de-Mesquita HB et al. (2005) Consumption of vegetables and fruits and risk of breast cancerGoogle Scholar
  98. — Watson M, Forster C, Eccles D et al. (2004) Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a genetic testing in a U.K. multi-centre clinical cohort.Google Scholar
  99. — Watson M, Haviland JS, Greer S et al. (1999) Influence of psychologic response on survival in breast cancer: A population-based cohort study. Lancet 354: 1331–6PubMedCrossRefGoogle Scholar
  100. — Watson T, Mock V (2004) Exercise as an intervention for cancer related fatigue. Phys Ther 84: 736–43PubMedGoogle Scholar
  101. — Wells M, Sarna L, Cooley M et al. (2007) Use of complementary and alternative medecins to control symptoms in women living with lung cancer. Cancer Nurs 30,1: 45–55PubMedCrossRefGoogle Scholar
  102. — WHO (2001) International classification of functioning, disabilities and health. www.WHO.int/classification/ICFGoogle Scholar
  103. — Yates P, Evans A, Moore A et al. (2007) Competency standards and educational requirements for specialist breast nurses in Australia. Collegium 14,1: 11–5Google Scholar
  104. — Zielinski CC (2004) Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer. Oncology 17,12: 36–40Google Scholar

Copyright information

© Springer-Verlag France, Paris 2007

Personalised recommendations